Skip to main content
Premium Trial:

Request an Annual Quote

Metabolon to Study Biofuel Metabolites for LS9

NEW YORK (GenomeWeb News) – The metabolomics-focused biomarker company Metabolon said on Tuesday that it has secured an agreement to test materials for the hydrocarbon biofuels developer LS9.
Metabolon said it will use its biochemical profiling service to identify changes in metabolites that occur during hydrocarbon biofuel production.
The focus will be to help LS9 optimize cellular metabolism in its Renewal Petroleum production process.
"As interest in the use of metabolomics has continued to grow, we have seen increased uptake from industry sectors like biofuel production," Metabolon CEO John Ryals said in a statement.
LS9’s technological aims are “well suited” for Metabolon’s biochemical profiling technology because it helps to provide “a picture of the reactions taking place at a biochemical level,” Ryals said.
Having that kind of a picture can have “an immediate and measurable impact on the fermentation processes,” Ryals added, which in turn “creates significant return in greater production and lowered cost.”
Financial terms of the agreement were not released.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.